Journal
DIABETES
Volume 60, Issue 5, Pages 1561-1565Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db10-0474
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft [203/2-2]
- Danish Medical Research Council
Ask authors/readers for more resources
OBJECTIVE-Glucagon-like peptide (GLP)-1 lowers postprandial glycemia primarily through inhibition of gastric emptying. We addressed whether the GLP-1-induced deceleration of gastric emptying is subject to rapid tachyphylaxis and if so, how this would alter postprandial glucose control. RESEARCH DESIGN AND METHODS-Nine healthy volunteers (25 +/- 4 years old, BMI: 24.6 +/- 4.7 kg/m(2)) were examined with intravenous infusion of GLP-1 (0.8 pmol . kg(-1) min(-1)) or placebo over 8.5 h. Two liquid mixed meals were administered at a 4-h interval. Gastric emptying was determined, and blood samples were drawn frequently. RESULTS-GLP-1 decelerated gastric emptying significantly more after the first meal compared with the second meal (P = 0.01). This was associated with reductions in pancreatic polypeptide levels (marker of vagal activation) after the first but not the second meal (P < 0.05). With GLP-1, glucose concentrations declined after the first meal but increased after the second meal (P < 0.05). The GLP-1-induced reductions in postprandial insulin and C-peptide levels were stronger during the first meal course (P < 0.05). Likewise, glucagon levels were lowered by GLP-1 after the first meal but increased after the second test meal (P < 0.05). CONCLUSIONS-The GLP-1-induced delay in gastric emptying is subject to rapid tachyphylaxis at the level of vagal nervous activation. As a consequence, postprandial glucose control by GLP-1 is attenuated after its chronic administration. Diabetes 60:1561-1565, 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available